These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8332962)

  • 1. Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitro.
    Brack MJ; More RS; Spring E; Gershlick AH
    Thromb Res; 1993 May; 70(4):329-35. PubMed ID: 8332962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.
    Doucet S; Malekianpour M; Théroux P; Bilodeau L; Côté G; de Guise P; Dupuis J; Joyal M; Gosselin G; Tanguay JF; Juneau M; Harel F; Nattel S; Tardif JC; Lespérance J
    Circulation; 2000 Mar; 101(9):955-61. PubMed ID: 10704160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phosphoinositide metabolism in endothelial cells of the human umbilical vein exposed to Y. pestis toxin].
    Cherkasova TD; Iurkiv VA; Pokrovskiĭ VI
    Biull Eksp Biol Med; 1994 Feb; 117(2):153-5. PubMed ID: 8012018
    [No Abstract]   [Full Text] [Related]  

  • 4. The internalization and release of heparins by cultured endothelial cells: the process is cell source, heparin source, time and concentration dependent.
    Hiebert LM; McDuffie NM
    Artery; 1990; 17(2):107-18. PubMed ID: 2155600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells.
    Seki Y; Toba K; Fuse I; Sato N; Niwano H; Takahashi H; Tanabe N; Aizawa Y
    Thromb Res; 2005; 115(3):219-28. PubMed ID: 15617745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells.
    Raab M; Daxecker H; Karimi A; Markovic S; Cichna M; Markl P; Müller MM
    Clin Chim Acta; 2001 Aug; 310(1):89-98. PubMed ID: 11485760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased prostacyclin production by human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin.
    Boutherin-Falson O; Blaes N
    Thromb Res; 1989 Jun; 54(5):487-92. PubMed ID: 2672410
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of arecoline in relaxing human umbilical vessels and inhibiting endothelial cell growth.
    Kuo FC; Wu DC; Yuan SS; Hsiao KM; Wang YY; Yang YC; Lo YC
    J Perinat Med; 2005; 33(5):399-405. PubMed ID: 16238534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin binding by human umbilical vein endothelial cells: effects of exogenous heparin.
    Justus AC; Roussev R; Norcross JL; Faulk WP
    Thromb Res; 1995 Jul; 79(2):175-86. PubMed ID: 7676404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of low dose nitroglycerin on plasma heparin concentrations and activated partial thromboplastin times.
    Brack MJ; More RS; Hubner PJ; Gershlick AH
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):183-6. PubMed ID: 8457649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sera, basic fibroblast growth factor, heparin and cyclic AMP-stimulation on proliferation of human vascular endothelial cells.
    Gillis C; Jonzon B; Haegerstrand A
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1131-8. PubMed ID: 8747094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin on endothelin-1 production by cultured human endothelial cells.
    Yokokawa K; Kohno M; Tahara H; Mandal AK; Yasunari K; Murakawa K; Horio T; Ikeda M; Minami M; Takeda T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S46-8. PubMed ID: 7509996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of in vitro interaction between heparin and nitroglycerin.
    Barnes AD; Horn JR; Wittkowsky AK
    Am J Clin Pathol; 1996 Mar; 105(3):298-300. PubMed ID: 8602610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of different nitrate preparations on plasma heparin concentrations and the activated partial thromboplastin time.
    Brack MJ; More RS; Hubner PJ; Gershlick AH
    Postgrad Med J; 1994 Feb; 70(820):100-3. PubMed ID: 8170877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
    Khorana AA; Sahni A; Altland OD; Francis CW
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia.
    Abrams J
    Am J Cardiol; 1992 Sep; 70(8):30B-42B. PubMed ID: 1529924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetics of binding of I-125-labeled heparin and its low-molecular-weight fraction CY 222 to the endothelium in vitro].
    Psuja P
    Acta Haematol Pol; 1987; 18(1-2):35-41. PubMed ID: 2829494
    [No Abstract]   [Full Text] [Related]  

  • 18. [The influence of hypoxia on the proliferation of endothelial cells originating from human umbilical vein (HUVEC)--an in vitro study].
    Bednarek W; Czekierdowski A; Kraczkowski J; Kotarski J
    Ginekol Pol; 2001 Dec; 72(12A):1567-71. PubMed ID: 11883316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin stimulates the release of glycosaminoglycans from cultured human endothelial cells.
    Kaji T; Sakuragawa N
    Thromb Res; 1990 Jan; 57(1):163-8. PubMed ID: 2300921
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitroglycerin-induced heparin resistance: absence of interaction at clinically relevant doses.
    Nottestad SY; Mascette AM
    Mil Med; 1994 Aug; 159(8):569-71. PubMed ID: 7824150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.